Robert W. Ross, Chief Medical Officer at Surface Oncology, Inc. (SURF), sold 1,405 shares at $10.05 ($14K) on 2020-12-11, disclosed to the SEC on 2020-12-15.
Scheduled sale ($14k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SURF | SELL | 2022-01-14 | $204K | — | Filing → |
| SURF | SELL | 2021-02-18 | $11K | — | Filing → |
| SURF | SELL | 2021-01-15 | $108K | — | Filing → |